Brokerages Set Roche Holding AG (OTCMKTS:RHHBY) PT at $57.00

Shares of Roche Holding AG (OTCMKTS:RHHBY) have been assigned an average rating of “Moderate Buy” from the eight brokerages that are currently covering the firm, Marketbeat reports. Two research analysts have rated the stock with a sell rating, two have assigned a hold rating, one has assigned a buy rating and three have given a strong buy rating to the company. The average 1-year price objective among brokers that have issued a report on the stock in the last year is $57.00.

A number of analysts have weighed in on the company. HSBC restated a “buy” rating and issued a $57.00 price target on shares of Roche in a research note on Wednesday, December 10th. Hsbc Global Res raised Roche from a “hold” rating to a “strong-buy” rating in a research report on Thursday, October 2nd. Deutsche Bank Aktiengesellschaft raised Roche from a “sell” rating to a “hold” rating in a report on Tuesday, November 11th. Jefferies Financial Group cut shares of Roche from a “hold” rating to a “moderate sell” rating in a report on Monday, October 27th. Finally, JPMorgan Chase & Co. upgraded shares of Roche from an “underweight” rating to a “neutral” rating in a research report on Monday, December 8th.

Hedge Funds Weigh In On Roche

Hedge funds have recently made changes to their positions in the company. Hancock Whitney Corp lifted its holdings in shares of Roche by 4.8% in the 3rd quarter. Hancock Whitney Corp now owns 24,488 shares of the company’s stock valued at $1,024,000 after purchasing an additional 1,116 shares during the last quarter. Verity Asset Management Inc. lifted its stake in Roche by 20.9% in the third quarter. Verity Asset Management Inc. now owns 10,990 shares of the company’s stock valued at $459,000 after buying an additional 1,898 shares during the last quarter. Douglass Winthrop Advisors LLC acquired a new stake in shares of Roche in the third quarter valued at approximately $201,000. Curio Wealth LLC acquired a new stake in shares of Roche in the third quarter valued at approximately $25,000. Finally, Vestmark Advisory Solutions Inc. acquired a new position in shares of Roche in the 3rd quarter valued at $597,000.

Roche Price Performance

Shares of RHHBY opened at $52.59 on Wednesday. The firm’s fifty day simple moving average is $46.23 and its 200-day simple moving average is $42.85. Roche has a twelve month low of $34.17 and a twelve month high of $52.59. The company has a debt-to-equity ratio of 0.80, a quick ratio of 1.02 and a current ratio of 1.29.

About Roche

Roche Holding AG is a Swiss multinational healthcare company headquartered in Basel, founded in 1896 by Fritz Hoffmann‑La Roche. The company operates primarily through two complementary divisions — Pharmaceuticals and Diagnostics — and is known for integrating drug development with diagnostic capabilities to advance personalized healthcare. In the United States and other international markets, shares trade as American Depositary Receipts under the ticker RHHBY (OTCMKTS:RHHBY).

In pharmaceuticals, Roche focuses on developing and commercializing prescription medicines across therapeutic areas including oncology, immunology, infectious diseases and neuroscience, with a notable emphasis on targeted biologics and personalized therapies.